Explore 3 Stock Ideas & Industry Insights Download Free Report

News

United Therapeutics CEO Martine Rothblatt Executes Planned Stock Sales and Option Exercise on Same Day

Martine A. Rothblatt, Chairperson and Chief Executive Officer of United Therapeutics Corporation (NASDAQ: UTHR), disclosed a series of equity transactions on July 28, 2026, involving the exercise of stock options and the sale of resulting shares pursuant to a pre-arranged trading plan. The transactions, …

Nitish Kishor | 28 July 2026

Globus Medical Director David Davidar Sells 2,500 Shares in Market Transaction

David Davidar, a director of Globus Medical Inc., disclosed the sale of 2,500 shares of Class A Common Stock on July 27, 2026, according to a regulatory filing submitted to the Securities and Exchange Commission. The transaction reduced Davidar's direct beneficial ownership in the …

Manish Choudhary | 28 July 2026

Avanos Medical CEO David Pacitti's Equity Positions Converted to Cash in $25 Per Share Merger Completion

Avanos Medical, Inc. completed its merger on July 27, 2026, with the company acquired at $25 per share in cash by A-AV Holdco I, Inc. Chief Executive Officer David Pacitti's equity holdings—including common stock, restricted stock units, performance-based equity awards, and stock options—were converted …

Aakashdeep | 28 July 2026

Avanos Medical CFO Scott Galovan's Stock Holdings Converted to Cash in $25-Per-Share Merger

Avanos Medical, Inc. (NYSE: AVNS) completed a merger transaction on July 27, 2026, in which all outstanding common stock was exchanged for $25.00 per share in cash. Scott Michael Galovan, the company's Senior Vice President and Chief Financial Officer, had his equity holdings—including common …

Manish Choudhary | 28 July 2026

Avanos Medical Executive Receives $25 Per Share Cash Consideration in Completed Merger Transaction

Avanos Medical, Inc. has completed a merger transaction in which shareholders received $25.00 per share in cash consideration. The merger became effective on July 27, 2026, according to a disclosure filed by Sigfrido Delgado, the company's Senior Vice President of Operations. The transaction involved …

Vinay Lochav | 28 July 2026

Velocity Financial CFO Mark Szczepaniak Sells 400 Shares in Company Stock Transaction

Mark R. Szczepaniak, Chief Financial Officer of Velocity Financial, Inc., disclosed a stock sale on July 28, 2026, according to a regulatory filing. Szczepaniak sold 400 shares of common stock at a weighted average price of $18.00 per share. The transaction was executed under …

Anjali Anand | 28 July 2026

Boyd Gaming CFO Josh Hirsberg Sells 12,777 Shares at Weighted Average Price of $89.76

Boyd Gaming Corporation disclosed that Josh Hirsberg, the company's Chief Financial Officer and Treasurer, sold 12,777 shares of common stock on July 28, 2026, at a weighted average price of $89.76 per share. The transaction, which was executed across multiple trades, reduces Hirsberg's direct …

Manish Choudhary | 28 July 2026

Saba Capital Management Sells Shares in BlackRock ESG Capital Allocation Term Trust

Saba Capital Management, L.P., a significant shareholder in BlackRock ESG Capital Allocation Term Trust, disclosed two equity transactions totaling approximately 198,382 shares sold between July 24 and July 27, 2026. The asset manager, which serves as a director of the closed-end fund, executed the …

Nitish Kishor | 28 July 2026

Elanco Animal Health CEO Jeffrey Simmons Acquires Deferred Stock Units in July Transaction

Elanco Animal Health Incorporated (NYSE: ELAN) disclosed that Jeffrey N. Simmons, President, Chief Executive Officer, and Director, acquired deferred stock units on July 24, 2026. The transaction involved 113.4857 deferred stock units valued at $24.91 per unit, according to a beneficial ownership filing released …

Shwetambri Chauhan | 28 July 2026

HeartFlow Director Jeffrey Lightcap Acquires Nearly 47,500 Shares in July 2026 Transaction

HeartFlow, Inc. (NASDAQ: HTFL) disclosed that Director Jeffrey C. Lightcap purchased 47,420 shares of common stock on July 24, 2026, at $19 per share, according to a regulatory filing released July 28, 2026. The transaction brings Lightcap's direct beneficial ownership to 293,681 shares. Lightcap, …

Aditi Sarkar | 28 July 2026
Support

Hi! How can we help you today?

Loading…